Seelos Therapeutics Inc (SEEL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché SEEL Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Seelos Therapeutics Inc Stock (SEEL) Company Profile

Seelos Therapeutics Inc

Healthcare (1204)

Biotechnology (683)

Prossima data di guadagno

Ultimi documenti SEC

SEEL's Discussions on Twitter

Confronta SEEL con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SEEL	0.39	0	0	-37.07M	-23.91M	-0.69
VRTX	467.01	119.87B	10.63B	-479.80M	-1.35B	13.33
REGN	762.00	83.27B	13.85B	4.65B	3.32B	35.06
ARGX	567.90	33.96B	1.86B	-40.29M	-1.28B	-4.16
ALNY	232.27	30.18B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.87	24.42B	3.30B	-501.07M	1.03B	11.54

Seelos Therapeutics Inc Stock (SEEL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2021-09-27	Aggiornamento	ROTH Capital	Neutral → Buy
2021-07-01	Iniziato	Guggenheim	Buy
2021-06-01	Iniziato	Cantor Fitzgerald	Overweight
2021-05-17	Downgrade	ROTH Capital	Buy → Neutral
2021-03-30	Iniziato	B. Riley Securities	Buy
2019-11-14	Iniziato	The Benchmark Company	Speculative Buy
2019-05-14	Iniziato	ROTH Capital	Buy

Mostra tutto

Seelos Therapeutics Inc Borsa (SEEL) Ultime notizie

Seelos Therapeutics Inc Azioni (SEEL) Dati Finanziari

Seelos Therapeutics Inc (SEEL)

Seelos Therapeutics Inc Stock (SEEL) Company Profile

Confronta SEEL con altri titoli

Seelos Therapeutics Inc Stock (SEEL) Upgrades & Downgrades

Seelos Therapeutics Inc Borsa (SEEL) Ultime notizie

Biopharm Co. Seelos Files For Ch. 11 After Nasdaq Delisting - Law360

Seelos Therapeutics Announces Registered Direct Offering of Common Stock and Warrants to Purchase Common Stock - Quantisnow

Seelos Therapeutics Announces 1-for-16 Reverse Stock Split - GuruFocus.com

Seelos Announces Postponement of its Annual Meeting of Stockholders - GuruFocus.com

SEELOS THERAPEUTICS INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com

Seelos Therapeutics announces the signing of a Material Transfer - GuruFocus.com

Seelos Announces Second Postponement of its Annual Meeting of Stockholders - StockTitan

Seelos Therapeutics (NASDAQ:SEEL) and Zoetis (NYSE:ZTS) Head-To-Head Contrast - Defense World

SEEL’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Closing Bell Recap: Seelos Therapeutics Inc (SEEL) Ends at 1.28, Reflecting a -47.76 Downturn - The Dwinnex

Seelos Therapeutics Delisted From Nasdaq, Will Transition To OTC Market - Benzinga

Seelos gets Nasdaq delisting notice - MSN

Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market - Morningstar

SEEL stock touches 52-week low at $2.37 amid market challenges By Investing.com - Investing.com South Africa

SEEL stock touches 52-week low at $2.37 amid market challenges - Investing.com

Seelos Therapeutics Inc (SEEL) Stock: A Year of Market Movement, Down and Up - The InvestChronicle

Financial Health Check: Examining Seelos Therapeutics Inc (SEEL)’s Key Ratios - The Dwinnex

Seelos Therapeutics faces Nasdaq delisting over share price By Investing.com - Investing.com Canada

Seelos Therapeutics faces Nasdaq delisting over share price - Investing.com

SEEL stock touches 52-week low at $2.77 amid market challenges By Investing.com - Investing.com South Africa

SEEL stock touches 52-week low at $2.77 amid market challenges - Investing.com Australia

Was Seelos Therapeutics Inc (SEEL)’s session last reading good? - US Post News

SEEL’s Financial Health: Exploring Seelos Therapeutics Inc’s Debt-to-Equity Ratio of 1.79 - The InvestChronicle

Nasdaq Moves Lower; Fed's Preferred Inflation Gauge Falls More Than Projected - Benzinga

Seelos Therapeutics approves reverse stock split By Investing.com - Investing.com South Africa

Seelos Therapeutics approves reverse stock split - Investing.com India

Seelos Therapeutics Announces Reverse Stock Split and Adjustments - TipRanks

Seelos Therapeutics to execute 1-for-16 reverse stock split - MSN

Taking the lead: Seelos Therapeutics Inc (SEEL) - SETE News

Investing in Seelos Therapeutics Inc (SEEL): What You Must Know - Knox Daily

Seelos Therapeutics announces 1-for-16 reverse stock split - TipRanks

3 Penny Stocks to Watch Now, 9/25/24 - TipRanks

Seelos to supply PTSD treatment for U.S. Army trial By Investing.com - Investing.com Australia

Seelos Therapeutics, Inc. (SEEL): A Strategic Move with SLS-002 in the Fight Against PTSD - BP Journal

Biotech Soars On Material Transfer Agreement - MSN

What's Going On With Seelos Therapeutics Stock Tuesday? - MSN

Seelos Therapeutics, Inc. Announces the Signing of A Material Transfer Agreement with the U.S. Army Medical Materiel Development Activity - Marketscreener.com

TSX Composite Dividend Index (TXDC) QuotePress Release - The Globe and Mail

TSX Composite Banks Index (TXBA) QuotePress Release - The Globe and Mail

TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail

Dow Futures Mini (YMH19) Quote - The Globe and Mail

Seelos Therapeutics Inc Inc. (SEEL) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Crude Oil Gains Over 1%; BioVie Shares Plunge - Benzinga

Seelos Therapeutics surges on deal with U.S. Army to develop PTSD drug - XM

Seelos to supply PTSD treatment for U.S. Army trial - Investing.com India

Seelos Therapeutics announces the signing of a Material Transfer Agreement with U.S. Army Medical Materiel Development Activity (USAMMDA) to evaluate SLS-002 for treatment of PTSD - PR Newswire

"Nasdaq Stocks Set for Explosive Growth: BNZI, SEEL, PRSO, MSS, HSCS Revamp for Big Potential" - openPR

What to expect from Esperion Therapeutics Inc.’s (ESPR) current quarter earnings? - US Post News

Integral Health Asset Management LLC Has $6.39 Million Stock Holdings in Mereo BioPharma Group plc (NASDAQ:MREO) - Defense World

Beck Capital Management LLC Reduces Stock Holdings in MercadoLibre, Inc. (NASDAQ:MELI) - Defense World

Is Seelos Therapeutics Inc (SEEL) worth investing in despite its undervalued state? - US Post News

Seelos Therapeutics Inc Azioni (SEEL) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a SEEL